Forgent Power Solutions stock analysis: revenue up 94.3% and a $3.0B backlog, but a 134.50 P/E and negative free cash flow keep the model at Hold.
Hold
-
-
Aerospace & DefenseUS Stocks
Planet Labs Jumps 8% on a Google AI-Satellite Launch – but 58% Growth at 15.86 Times Revenue Keeps the Model at Hold
Planet Labs PBC stock analysis: 58% revenue growth and positive free cash flow, but 15.86 times revenue keeps the model’s signal at Hold.
-
Health Care EquipmentUS Stocks
Intuitive Surgical Sits 33% Below Its Two-Year High – Why a 95/100 Quality Score Still Only Earns a Hold
Intuitive Surgical stock analysis: ISRG earns a 95/100 Quality score and 18.5% revenue growth, but a 46.12 P/E keeps the model at Hold.
-
Food & BeverageUS Stocks
PepsiCo Sinks to a Two-Year Low on a 16.87 P/E and 4.6% Yield – Yet the Model Stops Short of Buy
PepsiCo stock analysis: PEP hits a two-year low on a 16.87 P/E and 4.6% dividend yield. Why leverage and slow growth keep the model at Hold.
-
HardwareUS Stocks
Viavi Solutions: Revenue Up 52.5%, but a 36x EV/EBITDA Multiple Keeps the Signal at Hold
Viavi Solutions stock analysis: revenue up 52.5% and a 60.9% gross margin, but a net loss and 36x EV/EBITDA keep VIAV at Hold.
-
BiotechnologyUS Stocks
Madrigal’s Revenue Is Up 71% as Rezdiffra Ramps – the Stock Is Already Near Its Highs
Madrigal Pharmaceuticals stock analysis: 71% revenue growth meets a rich 24x price-to-book near two-year highs. Model signal: Hold.
-
Insmed Incorporated stock analysis: revenue up 296.1% with a 90/100 growth score, offset by a -76.9% net margin and a Hold signal from our model.